226 related articles for article (PubMed ID: 2558992)
21. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
22. [Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].
Nizze H; al-Thobhani AK; Terpe H
Zentralbl Chir; 1998; 123 Suppl 5():14-8. PubMed ID: 10063564
[TBL] [Abstract][Full Text] [Related]
23. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
[TBL] [Abstract][Full Text] [Related]
24. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
[No Abstract] [Full Text] [Related]
25. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
Richter-Ehrenstein C; Müller S; Noske A; Schneider A
Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
[TBL] [Abstract][Full Text] [Related]
27. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E
Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430
[No Abstract] [Full Text] [Related]
28. Kinetics of cellular proliferation and hormonal receptors in EVSA-T breast cancer cell line.
del Moral R; Fernández JC; López-González JD; Gómez M; Ruiz de Almodóvar JM; Olea N; Pedraza V
Rev Esp Fisiol; 1991 Mar; 47(1):25-30. PubMed ID: 1651547
[TBL] [Abstract][Full Text] [Related]
29. Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer.
Paradiso A; Ventrella V; Farchi G; Tommasi S; Mangia A; Barletta A; Schittulli F; Racanelli A; De Lena M
Oncology; 1993; 50(2):104-9. PubMed ID: 8383827
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
Seifert M; Wierrani F; Kubista E; Spona J
Gynakol Rundsch; 1991; 31 Suppl 2():397-8. PubMed ID: 1790992
[No Abstract] [Full Text] [Related]
32. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
Rosser RJ
Cancer; 2003 Sep; 98(5):1102-3; author reply 1103. PubMed ID: 12942582
[No Abstract] [Full Text] [Related]
33. [Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast].
Schmid KW; Hittmair A; Tötsch M; Müller E; Zaimet A; Tauscher T; Dünser M; Ofner D
Gynakol Rundsch; 1990; 30 Suppl 1():150-1. PubMed ID: 2079251
[No Abstract] [Full Text] [Related]
34. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
Mauriac L; Wafflart J; Trojani M; Durand M
Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE
West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of steroid hormone receptors with respect to tumor cellularity.
Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity in normal and neoplastic breast.
Tsao Jl; Zhao Y; Lukas J; Yang X; Shah A; Press M; Shibata D
Clin Cancer Res; 1997 Apr; 3(4):627-31. PubMed ID: 9815730
[TBL] [Abstract][Full Text] [Related]
39. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
Ronay G; Zimmermann HD; Tulusan AH
Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
[No Abstract] [Full Text] [Related]
40. Estrogen receptors in breast cancer; relationship to age, menstrual status and histological type.
Gómez P; Luna G; Beltrán ME; Hernández F
Arch Invest Med (Mex); 1987; 18(1):31-6. PubMed ID: 2820332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
